Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers’ DNA data

theglobeandmail.com/business/article-regeneron-agrees-to-buy-bankrupt-23andme-promises-ethical-use-of

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers’ DNA data.
Through the deal, Regeneron aims to bolster its capabilities in genomics-driven drug…

This story appeared on theglobeandmail.com, 2025-05-19 16:48:55.
The Entire Business World on a Single Page. Free to Use →